Antimicrobial Activity and Characteristics of Bacteriocin Producing Bacillus subtilis against Mastitis Pathogens

Juliana Maina^1, , Julius Maina Mathara¹, Gideon M. Kikuvi² and Eliud Wafula³

¹Department of Food Science and Technology, Jomo Kenyatta University of Agriculture and Technology, P. O Box 62000-00200, Nairobi, Kenya

²Department of Public Health, Jomo Kenyatta University of Agriculture, P. O Box 62000-00200, Nairobi, Kenya

³Department of Biological Sciences, Bomet University College, P.O. Box P.O 701-20400, Bomet, Kenya

Cite this paper:
Juliana Maina, Julius Maina Mathara, Gideon M. Kikuvi and Eliud Wafula. Antimicrobial Activity and Characteristics of Bacteriocin Producing Bacillus subtilis against Mastitis Pathogens. American Journal of Food Science and Technology. 2021; 9(1):20-29. doi: 10.12691/ajfst-9-1-4

Abstract

The use of drugs and antibiotics has increased the resistance of pathogenic bacteria in both animals and humans. This has been a significant problem and therefore triggers the investigation of novel antimicrobial agents produced by a bacterial strain of low virulence and having antimicrobial activity with a wide range of clinical significance. The use of bacteriocin has been extensively used in food industries, animals, and pharmaceutical industries. This is because it has been linked to antimicrobial activity, which has specific self-protection mechanisms. This study sought to evaluate antimicrobial activity and characteristics of bacteriocin producing Bacillus subtilis against Mastitis pathogens. For the screening of the isolates for bacteriocin properties against mastitis pathogens, antimicrobial activity was done using well diffusion methods on the nutrient agar. The results were obtained after 24hours and 48hours. Physiochemical characterization of the bacteriocin from Bacillus subtilis was determined at different temperatures of 60°C to 121°C for 15 minutes and monitor the effect of the temperature. The bacteriocin was also prepared at different pH (3-9) and incubated at room temperature; each sample's residual activity was determined against the indicator organisms. Metal ions (Cu²⁺, Zn²⁺, and Fe²⁺) on crude bacteriocin activity were determined to assess the residual antimicrobial activity by agar well diffusion assay. The results showed that bacteriocins from Bacillus subtilis were effective against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Klebsiella pneumonia. Physiochemical characterization showed that bacteriocin from different isolates had no inhibition from pH 3-5 and varied inhibition from pH 6-9 across the test organisms' isolates. On the temperature, crude bacteriocins at a temperature of 50°C to 60°C showed no activity loss based on initial activity. As temperature increases to 70°C to 80°C, there is reduced the bacteriocin activity of about 20%. 100°C had a 40% loss of the bacteriocin activity and 121°C with more than 50% loss of the activity. On metal ions, Cu²⁺, Fe²⁺, Zn²⁺ had a varied effect on bacteriocin activity against test organisms.

Keywords:
Bacillus subtilis Bacteriocin mastitis Escherichia coli Staphylococcus aureus Pseudomonas aeruginosa and Klebsiella pneumoniae

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Sahoo, K. C., Tamhankar, A. J., Johansson, E., & Lundborg, C. S. (2010). Antibiotic use, resistance development and environmental factors: a qualitative study among healthcare professionals in Orissa, India. BMC Public Health; 2010, 10(629), (21). 39 ref.
[2]	Ansari, A. (2015). Bacteriocin from LAB for Medical and Health Applications. In Min-Tze Liong (Ed.), Beneficial Microorganisms in Medical and Health Applications (1st ed., pp. 199-221). Springer International Publishing.
[3]	Ansari, A., Aman, A., Siddiqui, N. N., Iqbal, S., & Ul Qader, S. A. (2012). Bacteriocin (BAC-IB17): Screening, isolation and production from Bacillus subtilis KIBGE IB-17. Pakistan Journal of Pharmaceutical Sciences, 25(1), 195-201.
[4]	Yang, S.-C., Lin, C.-H., Sung, C. T., & Fang, J.-Y. (2014). Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Frontiers in Microbiology, 5(MAY), 241.
[5]	Pilasombut, K., Rumjuankiat, K., Ngamyeesoon, N., & Duy, L. N. D. (2015). In vitro Characterization of Bacteriocin Produced by Lactic Acid Bacteria Isolated from Nem Chua, a Traditional Vietnamese Fermented Pork. Korean Journal for Food Science of Animal Resources, 35(4), 473-478.
[6]	Dobson, A., Cotter, P. D., Ross, R. P., & Hill, C. (2012). Bacteriocin Production: a Probiotic Trait? Applied and Environmental Microbiology, 78(1), 1-6.
[7]	Salar, R. K., Siwach, P., Gahlawat, S. K., & Duhan, J. S. (2013). Biotechnology: Prospects and Applications. In R. K. Salar, S. K. Gahlawat, P. Siwach, & J. S. Duhan (Eds.), Biotechnology: Prospects and Applications. Springer India.
[8]	Silva, C. C. G., Silva, S. P. M., & Ribeiro, S. C. (2018). Application of Bacteriocins and Protective Cultures in Dairy Food Preservation. Frontiers in Microbiology, 9(APR), 594.
[9]	Cotter, P. D., Hill, C., & Ross, R. P. (2005). Bacteriocins: developing innate immunity for food. Nature Reviews Microbiology, 3(10), 777-788.
[10]	Abriouel, H., Franz, C. M. A. P., Ben Omar, N., & Gálvez, A. (2011). Diversity and applications of Bacillus bacteriocins. FEMS Microbiology Reviews, 35(1), 201-232.
[11]	Maina, J. W., Mathara, J. M., Kikuvi, G. M., & Ouma, S. O. (2017). Bacteriocins: Limiting Factors to Optimum Activity. Journal of Food Security, 5(2), 19-25.
[12]	Elayaraja, S., Annamalai, N., Mayavu, P., & Balasubramanian, T. (2014). Production, purification and characterization of bacteriocin from Lactobacillus murinus AU06 and its broad antibacterial spectrum. Asian Pacific Journal of Tropical Biomedicine, 4(Suppl 1), S305-S311.
[13]	Adinarayana, K., Ellaiah, P., & Prasad, D. S. (2003). Purification and partial characterization of thermostable serine alkaline protease from a newly isolated Bacillus subtilis PE-11. AAPS PharmSciTech, 4(4), E56.
[14]	Karaoglu, fiengül A., Aydin, F., S. Sirri, K., & Ali O, K. (2003). Antimicrobial Activity and Characteristics of Bacteriocins Produced by Vaginal Lactobacilli. Turkish Journal of Medical Science, 33, 7-13.
[15]	German, J. B., Freeman, S. L., Lebrilla, C. B., & Mills, D. A. (2008). Human milk oligosaccharides: Evolution, structures and bioselectiivty as substrates for intestinal bacteria. National Institute of Health, 62, 205-222.
[16]	Maina, J. W., Mathara, J. M., & Kikuvi, G. M. (2015). Isolation, Identification and Screening of Bacillus species from Rastrineobola argentea (Omena) for Production of Bacteriocins active against Bovine (Escherichia coli and Staphylococcus aureus) Mastitis Pathogens. Jomo Kenyatta University of Agriculture and Technology.
[17]	Maina, J., Mathara, J. M., & Kikuvi, G. M. (2015). Inhibition Of Bovine Mastitis Pathogens By Bacteriocins Produced By Bacillus Spp Isolated From Rastrineobola Argentea (Omena). International Journal of Life Sciences Research, 3(2), 146-154.
[18]	Kang, J. H., & Lee, M. S. (2005). Characterization of a bacteriocin produced by Enterococcus faecium GM-1 isolated from an infant. Journal of Applied Microbiology, 98(5), 1169-1176.